Dr. Farsad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-7660Fax+1 504-494-7664
Education & Training
Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 2006 - 2010
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurological Surgery, 2004 - 2005- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Transitional Year, 2003 - 2004
Yale School of MedicineClass of 2003
Certifications & Licensure
NH State Medical License 2005 - Present
WA State Medical License Current
MA State Medical License 2006 - 2025
OR State Medical License 2011 - 2025- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire Start of enrollment: 2017 Oct 25
Publications & Presentations
PubMed
- 339 citationsAmphiphysin 2 (Bin1) and T-tubule biogenesis in muscle.Eunkyung Lee, Melissa Marcucci, Laurie Daniell, Marc Pypaert, Ora A. Weisz
Science. 2002-08-16 - 4 citationsThe multidisciplinary management of cholangiocarcinoma.Kim C Ohaegbulam, Yilun Koethe, Alice Fung, Skye C Mayo, Aaron J Grossberg
Cancer. 2023-01-15 - 24 citationsA putative role for intramolecular regulatory mechanisms in the adaptor function of amphiphysin in endocytosis.Khashayar Farsad, Vladimir I. Slepnev, Gian-Carlo Ochoa, Laurie Daniell, Volker Hauke
Neuropharmacology. 2003-11-01
Press Mentions
Embolic Characteristics of Imipenem-Cilastatin Particles in Vitro and in Vivo: Implications for Transarterial Embolization in Joint ArthropathiesFebruary 16th, 2021
TACE-RT Ups Survival in Advanced HCCMarch 18th, 2018- Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliverMay 22nd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
